Virax Biolabs Group Total Liabilities

Virax Biolabs Group (VRAX) currently reports a total liabilities of $990K as of March 2026. That compares with $960K in the prior-year period — up 2.6% year over year. Use the charts on this page to explore Virax Biolabs Group's total liabilities history and peer comparisons.

Virax Biolabs Group's total liabilities increased from $960K to $990K — a 2.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Virax Biolabs Group reported $990K in total liabilities as of March 2026. That compares with $960K in the prior-year period — up 2.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $990K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Virax Biolabs Group, and consider following VRAX for alerts when major investors trade the stock.